author-photo

Richard S. Kornbluth

University of California, San Diego

61

Papers

3349

Citations

Citation Trend

Filter By

Papers (43) Sort By

Journal Conference Others

HIV-1 Adenoviral Vector Vaccines Expressing Multi-Trimeric BAFF and 4-1BBL Enhance T Cell Mediated Anti-Viral Immunity

2014 PLOS ONE
Show All
- Source
- Cite
- Save
Citations (15)
Multimeric forms of 4-1BBL as stimulators of T cells for adoptive immunotherapy

2014 Journal for ImmunoTherapy of Cancer
Show All
- Source
- Cite
- Save
Citations (0)
Vaccination with a Fusion Protein That Introduces HIV-1 Gag Antigen into a Multitrimer CD40L Construct Results in Enhanced CD8+ T Cell Responses and Protection from Viral Challenge by Vaccinia-Gag

2014 Journal of Virology
Show All
- Source
- Cite
- Save
Citations (6)
Design of CD40 Agonists and Their Use in Growing B Cells for Cancer Immunotherapy

2012 International Reviews of Immunology
Show All
- Source
- Cite
- Save
Citations (25)
In this issue: harnessing immunity against difficult targets, through the CD40-CD40L pathway.

2012 International Reviews of Immunology
- Richard S. Kornbluth
- Adrian Bot
Show All
- Source
- Cite
- Save
Citations (2)
Latent Membrane Protein 1 as a molecular adjuvant for single-cycle lentiviral vaccines

2011 Retrovirology
Show All
- Source
- Cite
- Save
Citations (5)
EBV LMP1, a viral mimic of CD40, activates dendritic cells and functions as a molecular adjuvant when incorporated into an HIV vaccine.

2011 Journal of Leukocyte Biology
Show All
- Source
- Cite
- Save
Citations (10)
Regression of Established AB1 Murine Mesothelioma Induced by Peritumoral Injections of CpG Oligodeoxynucleotide Either Alone or in Combination with Poly(I:C) and CD40 Ligand Plasmid DNA

2009 Journal of Thoracic Oncology
Show All
- Source
- Cite
- Save
Citations (18)
Nanoparticle-Delivered Multimeric Soluble CD40L DNA Combined with Toll-Like Receptor Agonists as a Treatment for Melanoma

2009 PLOS ONE
Show All
- Source
- Cite
- Save
Citations (66)
CD40L expressed from the canarypox vector, ALVAC, can boost immunogenicity of HIV-1 canarypox vaccine in mice and enhance the in vitro expansion of viral specific CD8+ T cell memory responses from HIV-1-infected and HIV-1-uninfected individuals.

2008 Vaccine
Show All
- Source
- Cite
- Save
Citations (46)